Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD+ pathway and SIRT1 activation

Post time 2024-4-21 10:35:24

期刊：Clinical Chemistry and Laboratory Medicine （CCLM）

作者：Caterina Lonati;乔治·别雷日诺伊;内森·劳勒;增田玲香;阿迪蒂·库尔卡尼;塞缪尔·萨拉;菲利普·尼奇克;莱姆多塔·齐兹马雷;丹尼尔·布奇;克莱尔·坎内特;哈特穆特·谢弗;约格什·辛格;尼古拉·格雷;萨曼莎·洛奇;杰里米·尼科尔森;乌塔·梅尔;朱利安·威斯特;克里斯托夫·特劳特温

发布日期：2024-3-25

DOI：10.1515/cclm-2023-1017

PDF链接：https：//www.degruyter.com/document/doi/10.1515/cclm-2023-1017/xml

文章链接：http：//dx.doi.org/10.1515/cclm-2023-1017

备注：

文章来源：Walter de Gruyter GmbH。

Post time 2024-4-21 10:35:25

: This post has been completed
Completed attachments will be deleted within 24 hours.

[De Gruyter] Urinary phenotyping of SARS-CoV-2 infection connects clinical diagnostics with metabolomics and uncovers impaired NAD+ pathway and SIRT1 activation

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today